Abstract
Results of the proton magnetic resonance spectroscopy carried out on normal, benign breast disease and locally advanced breast cancer patients are presented. The in-vivo MR spectra of malignant breast tissue of patients (n = 67) suffering from infiltrating ductal carcinoma are dominated by the water resonance, while the spectra of the unaffected contralateral breast tissue of these patients are mainly dominated by resonance arising from lipids which is similar to the spectra of normal breast tissue obtained from volunteers (controls, n = 16). In addition to the water and lipid peaks, in majority of the patients (∼80%) the water suppressed spectra showed a resonance at 3.2 ppm due to choline containing compounds (TCho) before treatment. In patients receiving neoadjuvant chemotherapy, absence/reduction in choline was observed in 89% of the patients. TCho was also observed in 2 of 14 benign lesions. The sensitivity and specificity of in-vivo MRS in detecting TCho in malignant tumours was 78% and 86%, respectively. Observation of TCho before treatment and its disappearance (or reduction) after treatment may be a useful indicator of response of locally advanced breast cancer to neoadjuvant chemotherapy. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bone B, Pentek Z, Perbeck L and Veres B (1997) Diagnostic accuracy or mammography and contrast enhanced MR imaging in 238 histological verified breast lesions. Acta Radiol 38: 489–496
Daniel BL, Yen YF, Glover GH, Ibeda DM, Birdwell RL, Glover AMS, Black JW, Plevritis SK and Herflens RJ (1998) Breast disease: dynamic spinal MR imaging. Radiology 209: 499–509
Degani H (1994). In: NMR in Physiology and Biomedicine, New York: Academic Press, pp. 329–351
Den Hollander JA, Luyten PR, Marien AJH, Segebarth CM, Baleriaux DF, De Beer R and Va Ormondt D (1989) Potentials of qualitative image localized human31P nuclear magnetic resonance spectroscopy in clinical evaluation of intracranial tumours. Mag Reson Quat 5: 152–168
Doyle VL, Barton SJ and Griffiths JR (1999) 31P and1H MRS of human cancer. Curr Sci 76: 772–776
Frahm J, Merboldt KD and Hanicke W (1987) Localized proton spectroscopy using stimulated echoes. J Magn Reson 72: 502–508
Friedrich M (1998) MRI of the breast: state of the art. Eur J Radiol 8: 707–725
Gilligam P, Flangan FL, Redmond OM, Walsh D, Carney DN and Ennis JT (1997) Proton magnetic resonance spectroscopy in MR mammographic evaluation of breast cancer. Proc Int Soc Magn Reson Med 5: 1378
Glaholm J, Leach MO, Collins DJ, Mansi J, Sharp JC, Madden A, Smith IE and McCready VR (1989) In-vivo31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer. Lancet 10: 1326–1327
Goel AK, Seenu V, Shukla NK and Raina VK (1995) Breast cancer presentation at a regional cancer center. Natl Med J India 8: 6–8
Gribbestad IS, Fjosne HE, Haugen OA, Nilsen G, Krane J, Petersen SB and Kvinnsland S (1993) In vitro proton NMR spectroscopy of extracts from human breast tumours and non- involved breast tissue. Anticancer Res 13: 1973–1980
Gribbestad IS, Nilsen G, Fjosne HE, Kvinnsland S and Krane J (1994) NMR spectroscopic characterization of perchloric acid extracts from breast carcinoma and non-involved breast tissue. NMR Biomed 7: 182–196
Gribbestad IS, Singstad TE, Nilsen G, Fjosne HE, Engan T, Haugen OA and Rinck PA (1998) In-vivo1H MRS of normal breast and breast tumours using a dedicated double breast coil. J Magn Reson Img 8: 1191–1197
Harms SE, Flemig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA and Wells RV (1993) MR imaging of the breast with rotating delivery of excitatation off resonance: clinical experience with pathologic correlation. Radiology 187: 493–501
Heywang-Kobrunner SH, Viehuray P, Heining A and Kuchler C (1997) Contrast-enhanced MRI of the breast; accuracy, value, controvarsies, solutions. Eur J Radiol 24: 94–108
Jagannathan NR and Sendhilvelan S (1993) Therapeutic response of tumors by in-vitro proton nuclear magnetic resonance spectroscopy. Appl Magn Reson 5: 357–367
Jagannathan NR, Meenakshi Singh, Govindaraju V, Raghunathan P, Coshic O, Julka PK and Rath GK (1998) Volume localized in-vivo proton MR spectroscopy of breast carcinoma: Variation of W/F ratio in patients receiving chemotherapy. NMR Biomed 11: 414–421
Jagannathan NR, Mahesh Kumar, Raghunathan P, Coshic O, Julka PK and Rath GK (1999) Assessment of the therapeutic response of human breast carcinoma using in-vivo volume localized proton magnetic resonance spectroscopy. Curr Sci 76: 777–782
Kaiser WA (1993) MR mammography, Radiologie 33: 292–299 and. Mdica Mundi 36: 168–182, 1991
Kasiomos JN, Merchant TE, Gierke LW and Glonek T (1990) 31P magnetic resonance spectroscopy of human colon cancer. Cancer Res 50: 527–532
Katz-Brull R, Margalit R, Bendel P and Degani H (1998) Choline meatbolism in breast cancer;2H13C and31P NMR studies of cells and tumors. MAGMA 6: 44–52
Kvistad KA, Bakken IJ, Gribbestad IS, Ehrnholm B, Lundgren S, Fjosne HE and Haraldseth O (1999) Characterization of neoplastic and normal human breast tissue with in-vivo1H MR spectroscopy. J Magn Reson Img 10: 159–164
Leach MO, Verrill M, Glaholm J, Smith TA, Collins DJ, Payne GS, Sharp JC, Ronen SM, McCready VR, Powles TJ and Smith IE (1998) Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized31P measurements of response to treatment. NMR Biomed 11: 314–340
Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, Doran ST, Barraclough BH, Bilous M and Mountford CE (1997) Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex-vivo with proton MR spectroscopy. Radiology 204: 661–666
Merchant TE, Gierke LW, Meneses P and Glonek T (1988) 31P Magnetic resonance spectroscopic profiles of neoplastic human breast tissues. Cancer Res 48: 5112–5118
NCRP (National Cancer Registry Programme) Biennial Report, (1988–1989). An Epidemiological Study, Indian Council of Medical Research: New Delhi (1992)
Orel SG (1998) High-resolution MR imaging for the detection, diagnosis, and staging of breast cancer. Radiographics 18: 903–912
Orel SG, Hochman MG, Schnall MD, Reynolds C and Sullivan DC (1996) High-resolution MR imaging of the breast: clinical context. Radiographics 16: 1385–1401
Payne GS, Dowsett M and Leach MO (1994) Harmone dependent metabolic changes in the normal breast monitored noninvasively by31P MR spectroscopy. Breast 3: 20–23
Piccoli CW (1997) Contrast-enhanced breast MRI: factors affecting sensitivity and specificity. Eur J Radiol 7 (suppl.5): 281–288
Roebuck JR, Cecil KM, Schnall MD and Lenkinski RE (1998) Human breast lesions: Characterization with proton MR spectroscopy. Radiology 209: 269–275
Sijens PE, Wijrdeman HK, Moerland MA, Bakker CJG, Vermeulen JWA and Luyten PR (1988) Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. Radiology 169: 615–620
Singer S, Souza K and Thilly WG (1995) Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: A31P and13C Nuclear Magnetic Resonance (NMR) spectroscopy study. Cancer Res 55: 5140–5145
Smith TAD, Eccles S, Ovmerod MG, Tombs AJ, Titley JC and Leach MO (1991) The phosphocholine and glycerophosphocholine content of an esterogen sensitive rat mammary tumor correlates strongly with growth rate. Br J Cancer 64: 821–826
Twelves CJ, Porter DA, Lowry M, Dobbs NA, Grover PE, Smith MA, Rubens RD and Richards MAC (1994) Phosphorus-31 metabolism of post-menopousal breast cancer studied in vivo by magnetic resonance spectroscopy. Br J cancer 69: 1151–1556
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Jagannathan, N., Kumar, M., Seenu, V. et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84, 1016–1022 (2001). https://doi.org/10.1054/bjoc.2000.1711
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1711
Keywords
This article is cited by
-
Probing lipids relaxation times in breast cancer using magnetic resonance spectroscopic fingerprinting
European Radiology (2023)
-
Imaging biomarkers for evaluating tumor response: RECIST and beyond
Biomarker Research (2021)
-
Dose-dependence of radiotherapy-induced changes in serum levels of choline-containing phospholipids; the importance of lower doses delivered to large volumes of normal tissues
Strahlentherapie und Onkologie (2021)
-
Biophysical review’s ‘meet the editors series’—a profile of Naranamangalam R. Jagannathan
Biophysical Reviews (2020)
-
Design and Simulation of a Helmholtz Coil for Magnetic Resonance Imaging and Spectroscopy Experiments with a 3T MR Clinical Scanner
Applied Magnetic Resonance (2019)